相关实验视频
Updated: Jan 9, 2026

08:31
Antibody-Free Assay for RNA Methyltransferase Activity Analysis
Published on: July 9, 2019
7.6K
METTL16成为一个关键的表转录体调节器,将RNA修饰,瘤进展和免疫调节联系起来
Qiang Wang1, Xiulin Jiang2, Yixiao Yuan2
1Department of Gastrointestinal Surgical Unit, Suining Central Hospital, Suining, Sichuan, China.
Frontiers in immunology
|December 1, 2025
概括
在癌症中,N6-甲基氨酸 (m6A) 修饰是关键. 甲基转移酶类16 (METTL16) 影响瘤生长,对治疗的反应和瘤微环境,提供新的精确瘤学点.
科学领域:
- 史诗转录组学 史诗转录组学
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- N6-甲基氨酸 (m6A) 是癌症中基因表达的关键表观遗传调节剂.
- 甲基转移酶类16 (METTL16) 是一种m6A甲基转移酶,影响瘤进展.
- METTL16的作用取决于情境,影响各种癌症的增殖,亡,自和化学反应.
研究的目的:
- 阐明METTL16在癌症中的多方面的作用.
- 研究METTL16对瘤进展和瘤微环境的影响.
- 探索METTL16作为精密瘤学的潜在目标.
主要方法:
- 对多种癌症类型中METTL16功能的累积证据的审查.
- 通过METTL16.16对目标基因的m6A-依赖调节的分析.
- 检查METTL16对mRNA稳定性,翻译和瘤微环境调节的影响.
主要成果:
- METTL16表现出取决于环境的瘤抑制或瘤促进功能.
- 通过m6A修饰,METTL16调节关键瘤基因和瘤抑制剂.
- METTL16影响瘤微环境中的免疫细胞透,免疫检查点和免疫逃避.
结论:
- METTL16是癌症中一个关键的表皮转录体调节剂.
- METTL16链接RNA修饰,瘤进展和免疫调节.
- 对于新型精确瘤学策略来说,METTL16是一个有前途的目标.
相关概念视频
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K

